A UC Riverside-led study, funded by Merck, is set to find out

UC Riverside study focused on how HIV mutates to escape the immune system

Research could lead to the design of new and better treatments to fight disease

Total funding of three grants exceeds $1.2 million

UC Riverside-led study finds persons with any HPV type, more than one HPV type, or high-risk HPV are more likely to test HIV positive

UC Riverside-led study in Southern California finds stigma, risk perceptions, and cost among major factors contributing to adults’ willingness to get HIV tested